The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cardiomyocyte Stiffness in Diastolic Heart Failure
Open accessAbstract
BACKGROUND: Heart failure with preserved left ventricular (LV) ejection fraction (EF) is increasingly recognized and usually referred to as diastolic heart failure (DHF). Its pathogenetic mechanism remains unclear, partly because of a lack of myocardial biopsy material. Endomyocardial biopsy samples obtained from DHF patients were therefore analyzed for collagen volume fraction (CVF) and sarcomeric protein composition and compared with control samples. Single cardiomyocytes were isolated from these biopsy samples to assess cellular contractile performance. METHODS AND RESULTS: DHF patients (n=12) had an LVEF of 71+/-11%, an LV end-diastolic pressure (LVEDP) of 28+/-4 mm Hg, and no significant coronary artery stenoses. DHF patients had higher CVFs (7.5+/-4.0%, P<0.05) than did controls (n=8, 3.8+/-2.0%), and no conspicuous changes in sarcomeric protein composition were detected. Cardiomyocytes, mechanically isolated and treated with Triton X-100 to remove all membranes, were stretched to a sarcomere length of 2.2 microm and activated with solutions containing varying [Ca2+]. Compared with cardiomyocytes of controls, cardiomyocytes of DHF patients developed a similar total isometric force at maximal [Ca2+], but their resting tension (F(passive)) in the absence of Ca2+ was almost twice as high (6.6+/-3.0 versus 3.5+/-1.7 kN/m2, P<0.001). F(passive) and CVF combined yielded stronger correlations with LVEDP than did either alone. Administration of protein kinase A (PKA) to DHF cardiomyocytes lowered F(passive) to control values. CONCLUSIONS: DHF patients had stiffer cardiomyocytes, as evident from a higher F(passive) at the same sarcomere length. Together with CVF, F(passive) determined in vivo diastolic LV dysfunction. Correction of this high F(passive) by PKA suggests that reduced phosphorylation of sarcomeric proteins is involved in DHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased Fpassive has been observed in HFpEF patient biopsies, and increased cardiac stiffening is associated with aging.38,39”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Kawaguchi, M., Hay, I., Fetics, B. J., & Kass, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000048123.22359.a0 · Cited by 929
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease
Brilla, C. G., FUNCK, R. C., & Rupp, H. (2000) · Circulation · doi:10.1161/01.cir.102.12.1388 · Cited by 653
How to diagnose diastolic heart failure
Paulus, W. J., Brutsaert, D. L., Gillebert, T. C., Rademakers, F., Stanislas, U., Leite-Moreira, A. F., Om, H., Zh, J., Kaufmann, P. A., Mandinov, L., et al. (1998) · Ghent University Academic Bibliography (Ghent University) · Cited by 649
How to diagnose diastolic heart failure
European Study Group on Diastolic H (1998) · European Heart Journal · doi:10.1053/euhj.1998.1057 · Cited by 616
Research works printed but not linked: 9
Cited by
Sorted by citations
Items 301–400 of 534
Considerations for Clinical Trials Targeting the Myocardial Interstitium
Lewis, G. A., Dodd, S. R., Naish, J. H., Selvanayagam, J. B., Dweck, M. R., & Miller, C. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.03.034 · Cited by 19
Habel, N., Infeld, M. M., Bernknopf, J., Meyer, M., & Lustgarten, D. L. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.12.001 · Cited by 19
Hiraiwa, H., Okumura, T., & Murohara, T. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00641-9 · Cited by 19
Cardiac myofilaments: from proteome to pathophysiology
Jin, W., Brown, A. T., & Murphy, A. M. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780075 · Cited by 17
Ali, D., Callan, N., Ennis, S., Powell, R., McGuire, S., McGregor, G., Weickert, M. O., Miller, M. A., Cappuccio, F. P., & Banerjee, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027984 · Cited by 16
Coronary Microvascular Dysfunction: Features and Prognostic Value
Kopeva, K. V., Grakova, E. V., Maltseva, A. N., Mochula, A. V., Гусакова, А. М., Smorgon, A., & Zavadovsky, K. V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082964 · Cited by 16
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
Jalink, E. A., Schonk, A. W., Boon, R. A., & Juni, R. P. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1300375 · Cited by 16
Kattih, B., Fischer, A., Muhly-Reinholz, M., Tombor, L. S., Nicin, L., Cremer, S., Zeiher, A. M., John, D., Abplanalp, W. T., & Dimmeler, S. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.11.004 · Cited by 16
Krittanawong, C., & Kukin, M. L. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0623-1 · Cited by 16
Zeng, J., Zhou, Y., & Zhu, Y. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666211129111202 · Cited by 16
Bódi, B., Oláh, A., Mártha, L., Tóth, A., Radovits, T., Merkely, B. P., & Papp, Z. L. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204119 · Cited by 16
Mannacio, V. A., Guadagno, E., Mannacio, L., Cervasio, M., Antignano, A., Mottola, M., Gagliardi, C., & Vosa, C. (2015) · Cardiology · doi:10.1159/000431283 · Cited by 16
Fontes-Sousa, A. P., Brás‐Silva, C., Pires, A. L., Sousa, D. M., & Leite-Moreira, A. F. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0180-8 · Cited by 16
Microstructure-based finite element model of left ventricle passive inflation
Xi, C., Kassab, G. S., & Lee, L. C. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.04.016 · Cited by 15
Heart Failure With Preserved Ejection Fraction: An Evolving Understanding
Tah, S., Valderrama, M., Afzal, M., Iqbal, J., Farooq, A., Lak, M. A., Gostomczyk, K., Jami, E., Kumar, M., Sundaram, A., et al. (2023) · Cureus · doi:10.7759/cureus.46152 · Cited by 17
Heart failure with preserved ejection fraction
Alsamara, M., & Alharethi, R. A. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.911086 · Cited by 14
Hubesch, G., Hanthazi, A., Acheampong, A., Chomette, L., Lasolle, H., Hupkens, E., Jespers, P., Vegh, G., Wembonyama, C. W. M., Verhoeven, C., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.809885 · Cited by 15
Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations
van Dijk, S. J., Boontje, N. M., Heymans, M. W., ten Cate, F. J., Michels, M., dos Remedios, C. G., Dooijes, D., van Slegtenhorst, M. A., van der Velden, J., & Stienen, G. J. M. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1391-0 · Cited by 15
Myeloperoxidase impairs the contractile function in isolated human cardiomyocytes
Kalász, J., Pásztor, E. T., Fagyas, M., Balogh, Á., Tóth, A., Csató, V., Edes, I. F., Papp, Z., & Borbély, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.036 · Cited by 15
Kov́acs, Á., Herwig, M., Budde, H., Delalat, S., Kolijn, D., Bódi, B., Hassoun, R., Tangos, M., Zhazykbayeva, S., Balogh, Á., et al. (2021) · Antioxidants · doi:10.3390/antiox10060964 · Cited by 15
Hasegawa, S., Yamamoto, K., Sakata, Y., Takeda, Y., Kajimoto, K., Kanai, Y., Hori, M., & Hatazawa, J. (2008) · Hypertension Research · doi:10.1291/hypres.31.1157 · Cited by 15
Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure
Dhalla, N. S., Mota, K. O., Vijayan Elimban, A., Shah, A. K., de Vasconcelos, C. M. L., & Bhullar, S. K. (2024) · Cells · doi:10.3390/cells13100856 · Cited by 14
Heart failure with preserved ejection fraction: The role of inflammation
Liu, H., Magaye, R., Kaye, D. M., & Wang, B. H. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176858 · Cited by 17
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation
Cuijpers, I., Papageorgiou, A., Carai, P., Herwig, M., Mügge, A., Klein, T., Hamdani, N., Jones, E. A. V., & Heymans, S. R. B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16122 · Cited by 13
Lorenzi, A. B. D., Kaplinsky, E., Zambrano, M. R., Chaume, L. T., & Rosas, J. M. (2023) · Drugs in Context · doi:10.7573/dic.2022-7-1 · Cited by 16
Kalász, J., Pásztorńe, E. T., Bódi, B., Fagyas, M., Tóth, A., Bhattoa, H. P., Vari, S. G., Balog, M., Blažetić, S., Heffer, M., et al. (2014) · Croatian Medical Journal · doi:10.3325/cmj.2014.55.239 · Cited by 14
Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus
Gonçalves, N., Gomes-Ferreira, C., Moura, C., Roncon‐Albuquerque, R., Leite-Moreira, A. F., & Falcão‐Pires, I. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.178 · Cited by 14
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
Graziani, F., Lillo, R., & Crea, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.678530 · Cited by 14
Heart Failure with Normal Ejection Fraction
Redfield, M. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00030-5 · Cited by 13
Huang, H., Ruan, Q., Lin, M., Yan, L., Huang, C., & Fu, L. (2017) · Cardiovascular Ultrasound · doi:10.1186/s12947-017-0106-7 · Cited by 13
Anderson, T., Hummel, S. L., & Konerman, M. C. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.07.001 · Cited by 14
A cell-based framework for modeling cardiac mechanics
Telle, Å., Trotter, J. D., Cai, X. H., Finsberg, H. N. T., Kuchta, M., Sundnes, J., & Wall, S. (2023) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-022-01660-8 · Cited by 13
New Insights Into Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction
Gelzinis, T. A. (2013) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253213510748 · Cited by 13
Šoltić, D., Shorrock, H. K., Allardyce, H., Wilson, E. L., Holt, I., Synowsky, S. A., Shirran, S. L., Parson, S. H., Gillingwater, T. H., & Fuller, H. R. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz195 · Cited by 15
Wiech, P., Würzburger, L., Rossi, V. A., Caselli, S., Schmied, C. M., & Niederseer, D. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02195-3 · Cited by 12
Increased Chamber Resting Tone Is a Key Determinant of Left Ventricular Diastolic Dysfunction
Tamargo, M., Martínez‐Legazpi, P., Espinosa, M. Á., Lyon, A., Méndez, I., Gutiérrez, E., Fernández, A. I., Prieto-Arévalo, R., González‐Mansilla, A., Arts, T. G. J., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010673 · Cited by 12
Breakthrough in heart failure with preserved ejection fraction: are we there yet?
Lim, S. L., & Lam, C. S. P. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.31.1.1 · Cited by 13
Wu, L., Shi, R., Wu, C., Jiang, M., Guo, Q., Zhu, Y., Tang, L., Xu, J., Pu, J., Zhou, Y., et al. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28070 · Cited by 12
Guo, A., Chen, R., Wang, Y., Huang, C.-K., Chen, B., Kutschke, W. J., Jiang, H., & Song, L. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.003 · Cited by 12
Öztürk, Ç., Rosalia, L., & Roche, E. T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.815787 · Cited by 11
Insuficiência cardíaca com fração de ejeção normal
Roscani, M. G., Matsubara, L. S., & Matsubara, B. B. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010000500019 · Cited by 12
Variation in stiffness regulates cardiac myocyte hypertrophy via signaling pathways
Li, J., Mkrtschjan, M. A., Lin, Y., & Russell, B. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0578 · Cited by 12
Canto, E. D., Scheffer, M., Kortekaas, K. A., Driessen‐Waaijer, A., Paulus, W. J., & van Heerebeek, L. (2023) · Biomedicines · doi:10.3390/biomedicines11030867 · Cited by 11
Sidhu, G., & Rabkin, S. W. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185533 · Cited by 11
Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy
Arnold, Z., Dostal, C., Szabó, P. L., Aykac, I., Goncalves, A. I. A., Sousa, S. L., Baydar, S., Budde, H., Váradi, B., Nádasy, G. L., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02780-y · Cited by 11
How Cardiomyocytes Make the Heart Old
Papp, Z. L., Czuriga, D., Balogh, L., Balogh, A., & Borbély, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112804583104 · Cited by 11
Heart Failure With Preserved Ejection Fraction
Jumean, M. F., & Konstam, M. A. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000057 · Cited by 11
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
Zach, V., Baehr, F., & Edelmann, F. (2020) · Cardiac failure review · doi:10.15420/cfr.2019.10 · Cited by 12
Macrae, R. G. C., Colzani, M., Williams, T., Bayraktar, S., Kuc, R. E., Pullinger, A. L., Bernard, W. G., Robinson, E. L., Davenport, E. E., Maguire, J. J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac065 · Cited by 11
Future strategies for the treatment of diastolic heart failure
Feld, Y., Dubi, S., Reisner, Y., Schwammenthal, E., & Elami, A. (2006) · Acute Cardiac Care · doi:10.1080/14628840600548988 · Cited by 11
Glycation in the cardiomyocyte
Delligatti, C. E., & Kirk, J. A. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.04.005 · Cited by 10
A multidimensional sight on cardiac failure: uncovered from structural to molecular level
Urmaliya, V., & Franchelli, G. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9610-y · Cited by 10
Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction
Yamamoto, K. (2017) · Yonago acta medica · doi:10.33160/yam.2017.06.001 · Cited by 10
Akerman, J., Heckman, G. A., & McKelvie, R. S. (2014) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614542224 · Cited by 12
Deliberations on Diastolic Heart Failure
Gaasch, W. H. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.093 · Cited by 10
Force properties of skinned cardiac muscle following increasing volumes of aerobic exercise in rats
Boldt, K., Rios, J. L., Joumaa, V., & Herzog, W. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00631.2017 · Cited by 10
Lewis, G. A., Rosala‐Hallas, A., Dodd, S. R., Schelbert, E. B., Williams, S. G., Cunnington, C., McDonagh, T. A., & Miller, C. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10264-7 · Cited by 10
The myocardial flow reserve in patients with heart failure with preserved ejection fraction
Mochula, A. V., Kopeva, K. V., Maltseva, A. N., Grakova, E. V., Gulya, M. O., Сморгон, А. В., Гусакова, А. М., & Zavadovsky, K. V. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02161-5 · Cited by 9
Zakeri, R., Vallejo‐Giraldo, C., & Taylor, K. E. (2011) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s1-006 · Cited by 9
Tóth, N., Soós, A., Váradi, A., Hegyi, P. J., Tinusz, B., Vágvölgyi, A., Orosz, A., Solymár, M., Polyák, A., Varró, A., et al. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0700 · Cited by 9
Jia, R., Ji, Y., & Sun, D. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113701 · Cited by 9
Zhang, Y., Zhang, X., Wang, Y., Hu, X., Wang, B., Yang, J., Zhao, X., & Zhang, L. (2023) · European Journal of Radiology · doi:10.1016/j.ejrad.2023.110848 · Cited by 9
Sucato, V., Galassi, A. R., Novo, S., Saladino, A., Evola, S., & Novo, G. (2019) · Microcirculation · doi:10.1111/micc.12605 · Cited by 9
Heart Failure with Preserved Ejection Fraction and Diabetes Mellitus
Magri, C. J., Cassar, A., Fava, S., & Felice, H. (2012) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-1-2 · Cited by 9
Jani, V., Koleini, N., Fenwick, A. J., Sharp, T. E., Goodchild, T. T., Hill, J. A., Lefer, D. J., Cammarato, A., & Kass, D. A. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.10.005 · Cited by 8
Takei, Y., Tomiyama, H., Higashi, Y., Yamashina, A., & Chikamori, T. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0810 · Cited by 9
Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure
Lewalle, A., Land, S., Merken, J. J., Raafs, A. G., Sepúlveda, P., Heymans, S. R. B., Kleinjans, J. C. S., & Niederer, S. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.07.033 · Cited by 8
Das, B. B. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00508-z · Cited by 7
Brown, S. J., Šoltić, D., Synowsky, S. A., Shirran, S. L., Chilcott, E. M., Shorrock, H. K., Gillingwater, T. H., Yáñez‐Muñoz, R. J., Schneider, B. L., Bowerman, M., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad121 · Cited by 8
Heart failure with preserved ejection fraction (diastolic heart failure)
Czuriga, I., Borbély, A., Czuriga, D., Papp, Z., & Edes, I. F. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29506 · Cited by 8
van Heerebeek, L. (2014) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/1/2/00112 · Cited by 8
Farré, N., Jorba, I., Torres, M., Falcones, B., Martí‐Almor, J., Farré, R., Almendros, I., & Navajas, D. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01545 · Cited by 8
Kakkad, V., LeFevre, M., Hollender, P. J., KISSLO, J. A., & Trahey, G. E. (2019) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.12.011 · Cited by 11
Transition of Left Ventricular Ejection Fraction in Heart Failure
Sakata, Y., Tsuji, K., Nochioka, K., & Shimokawa, H. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_178 · Cited by 8
Cheitlin, M. D. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70199-5 · Cited by 8
Kovács, Á., Zhazykbayeva, S., Herwig, M., Fülöp, G., Csípő, T., Oláh, N., Hassoun, R., Budde, H., Osman, H., Kaçmaz, M., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01160-w · Cited by 6
Papp, Z., Borbély, A., & Paulus, W. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264242 · Cited by 7
de Groot, N. E., van den Hoogenhof, M. M. G., Najafi, A., van der Made, I., van der Velden, J., Beqqali, A., Pinto, Y. M., & Creemers, E. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-64667-0 · Cited by 7
Burrage, M. K., Lewis, A. J., & Miller, J. J. J. J. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-022-07355-7 · Cited by 7
Heart Failure with Preserved Ejection Fraction (HFpEF)
Francis, G. S., Alraies, M. C., & PRITZKER, M. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-44577-9_13 · Cited by 7
MacNamara, J. P., Koshti, V., Cheng, I., Dias, K. A., Hearon, C. M., Cornwell, W. K., Howden, E. J., Levine, B. D., & Sarma, S. (2021) · Echocardiography · doi:10.1111/echo.14975 · Cited by 7
Dhalla, N. S., Bhullar, S. K., & Shah, A. K. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0154 · Cited by 7
Intrinsic nanomechanical changes in live diabetic cardiomyocytes
(2015) · Cardiovascular Regenerative Medicine · doi:10.14800/crm.893 · Cited by 7
Varadarajan, V., Marques, M. D., Ambale‐Venkatesh, B., Allison, M., Ostovaneh, M. R., Yoneyama, K., Donekal, S., Shah, R. V., Murthy, V. L., Wu, C. O., et al. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad050 · Cited by 6
Mohananey, D., Heidari‐Bateni, G., Villablanca, P. A., Murrieta, J. I., Vlismas, P. P., Agrawal, S., Bhatia, N., Mookadam, F., & Ramakrishna, H. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.11.023 · Cited by 6
Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis
Falcão‐Pires, I., Gavina, C., & Leite-Moreira, A. F. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011208062485 · Cited by 6
Decreasing Compensatory Ability of Concentric Ventricular Hypertrophy in Aortic-Banded Rat Hearts
Lewalle, A., Land, S., Carruth, E. D., Frank, L. R., Lamata, P., Omens, J. H., McCulloch, A. D., Niederer, S., & Smith, N. P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00037 · Cited by 6
Eslam, R. B., Öztürk, B., Panzer, S., Qin, H., Duca, F., Binder, C., Rettl, R., Dachs, T.-M., Alasti, F., Vila, G., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.04.029 · Cited by 6
Vinereanu, D., & Margulescu, A. D. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.828 · Cited by 6
Aging and Heart Failure with Preserved Ejection Fraction
Larson, K. F., Malik, A., & Brozovich, F. V. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210035 · Cited by 12
Kim, T., Sheen, M., Ryan, D., & Joseph, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020673 · Cited by 6
Li, Y., Wang, C., Hung, C., Wu, Y., Hsu, C., Tsou, Y., Wang, C., Wu, C., Lin, P., Chang, H., et al. (2024) · PubMed Central · doi:10.6515/acs.202403_40(2).20240206a · Cited by 5
Gonçalves‐Rodrigues, P., Miranda‐Silva, D., Li, X., Sousa-Mendes, C., Martins-Ferreira, R., Elbeck, Z., Leite-Moreira, A. F., Knöll, R., & Falcão‐Pires, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249687 · Cited by 5
Prognostic implications of fibrosis in low risk aortic stenosis patients
Gavina, C., Falcão‐Pires, I., Santos-Faria, J., Marinho, B., Almeida, J., Rodrigues, J., Pinho, P. R. A., Rocha‐Gonçalves, F., & Leite-Moreira, A. F. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.02.017 · Cited by 5
Lipids: a Potential Molecular Pathway Towards Diastolic Dysfunction in Youth-Onset Type 2 Diabetes
SHAH, A. S., Sadayappan, S., & Urbina, E. M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-00989-w · Cited by 6
Waddingham, M. T., Sequeira, V., Kuster, D. W. D., Canto, E. D., Handoko, M. L., de Man, F. S., Bós, D. D. S. G., Ottenheijm, C. A. C., Shen, S., van der Pijl, R. J., et al. (2023) · Physiological Reports · doi:10.14814/phy2.15788 · Cited by 5
Invasive Evaluation of Diastolic Left Ventricular Dysfunction
van Heerebeek, L., & Paulus, W. J. (2008) · Springer eBooks · doi:10.1007/978-1-84628-891-3_9 · Cited by 5
Lewis, G. A., Pearce, K., Williams, S. G., Schelbert, E. B., Macnab, A., & Miller, C. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10047-9 · Cited by 7
Pathophysiology of Diastolic Heart Failure: Relaxation and Stiffness
Bonnema, D. D., Baicu, C. F., & Zile, M. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3754-5.50008-1 · Cited by 5
Deciphering human heart failure with preserved ejection fraction (HFpEF) at single cell resolution
Zanders, L., Glaser, S.-F., Jurado, M. R., Brandt, M., John, D., Nicin, L., Morales, D. R., Abplanalp, W. T., Procida‐Kowalski, T., Ganß, F., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf784.1016 · Cited by 4
Metadata
- Authors
- Borbély, A., van der Velden, J., Papp, Z., Bronzwaer, J. G. F., Edes, I., Stienen, G. J. M., & Paulus, W. J.
- Affiliations
- From the Laboratory for Physiology (A.B., J.v.d.V., J.G.F.B., G.J.M.S., W.J.P.), Institute for Cardiovascular Research, VUMC, Amsterdam, the Netherlands, and the Division of Clinical Physiology (A.B., Z.P., I.E.), Institute of Cardiology, UDMHSC, Debrecen, Hungary.
- Amsterdam Cardiovascular Sciences (NL)
- Venue
- Circulation
- Published
- 2005-02-15
- Volume
- 111
- Issue
- 6
- Pages
- 774-781
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2140058582
- Cited by
- 536
- References
- 44
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 21 · 2023: 24 · 2022: 25 · 2021: 28 · 2020: 37 · 2019: 20 · 2018: 28 · 2017: 32 · 2016: 35 · 2015: 30 · 2014: 35 · 2013: 24 · 2012: 20
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- heart failure with preserved ejection fraction, cardiomyocyte stiffness, passive tension, collagen volume fraction, sarcomeric proteins, protein kinase A, sarcomere length, diastolic dysfunction, left ventricular end-diastolic pressure, myocardial fibrosis
- MeSH terms
- Aged, Aged, 80 and over, Calcium, Diastole, Female, Heart Failure, Hemodynamics, Humans, Male, Middle Aged, Myocardium, Stroke Volume, Ventricular Function, Left, Ventricular Pressure, Cyclic AMP-Dependent Protein Kinases, Myocytes, Cardiac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
